Jeffrey S. Ginsberg
#129,922
Most Influential Person Now
Jeffrey S. Ginsberg's AcademicInfluence.com Rankings
Jeffrey S. Ginsbergphilosophy Degrees
Philosophy
#6273
World Rank
#9280
Historical Rank
Logic
#3453
World Rank
#4611
Historical Rank

Download Badge
Philosophy
Why Is Jeffrey S. Ginsberg Influential?
(Suggest an Edit or Addition)Jeffrey S. Ginsberg's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer (2000) (1517)
- A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. (1996) (1191)
- A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. (1999) (1125)
- Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism (1998) (995)
- Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. (1997) (773)
- Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. (2003) (741)
- Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. (2000) (679)
- Use of antithrombotic agents during pregnancy. (1992) (672)
- Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. (2009) (662)
- Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. (1998) (638)
- Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. (2008) (583)
- Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review (1999) (549)
- Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004) (512)
- Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. (1990) (486)
- A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. (2000) (481)
- The Role of Venous Ultrasonography in the Diagnosis of Suspected Deep Venous Thrombosis and Pulmonary Embolism (1998) (441)
- Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial (2014) (425)
- Determinants of health‐related quality of life during the 2 years following deep vein thrombosis (2008) (420)
- Relationship between deep venous thrombosis and the postthrombotic syndrome. (2004) (414)
- The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. (2014) (384)
- Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis (1995) (383)
- Antiphospholipid antibodies and venous thromboembolism. (1995) (381)
- Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. (1996) (370)
- Deep vein thrombosis and its prevention in critically ill adults. (2001) (340)
- Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. (2003) (325)
- A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. (1994) (310)
- Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. (1998) (286)
- Prevention and treatment of postphlebitic syndrome: results of a 3-part study. (2001) (276)
- Management of venous thromboembolism. (1996) (272)
- Optimal therapeutic level of heparin therapy in patients with venous thrombosis. (1992) (258)
- Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. (2005) (255)
- Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. (2000) (249)
- Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? (2001) (232)
- Treatment of Deep-Vein Thrombosis (2004) (226)
- The post-thrombotic syndrome: current knowledge, controversies, and directions for future research. (2002) (223)
- Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread (1999) (222)
- Ximelagatran versus Warfarin for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty (2002) (219)
- Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. (1998) (214)
- Management of Suspected Deep Venous Thrombosis in Outpatients by Using Clinical Assessment and d-dimer Testing (2001) (213)
- Venous Thrombosis during Pregnancy: Leg and Trimester of Presentation (1992) (211)
- Incidence of venographically proved deep vein thrombosis after knee arthroscopy. (1998) (204)
- The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group. (1998) (200)
- Risks to the Fetus of Anticoagulant Therapy During Pregnancy (1989) (197)
- Heparin therapy during pregnancy. Risks to the fetus and mother. (1989) (190)
- Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. (2002) (185)
- Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis (2005) (185)
- Comparison of Venography and Ultrasound for the Diagnosis of Asymptomatic Deep Vein Thrombosis in the Upper Body in Children (2002) (184)
- Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. (2004) (183)
- Risks to the Fetus of Radiologic Procedures Used in the Diagnosis of Maternal Venous Thromboembolic Disease (1989) (179)
- Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study. (2001) (175)
- Does this patient have pulmonary embolism? (2003) (173)
- Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular- Weight Heparin for Acute Treatment of Venous Thromboembolism (2006) (166)
- The Effects of Long-term Heparin Therapy During Pregnancy on Bone Density (1996) (157)
- Oral Anticoagulation Therapy in Pediatric Patients: a Prospective Study (1994) (155)
- Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double‐blind study (2003) (152)
- Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor (2004) (150)
- Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study. (2000) (145)
- Anticoagulation of pregnant women with mechanical heart valves. (2003) (144)
- Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. (1991) (143)
- Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial (2009) (143)
- A Diagnostic Strategy Involving a Quantitative Latex d-Dimer Assay Reliably Excludes Deep Venous Thrombosis (2003) (142)
- Clinical Utility of a Rapid Whole-Blood d-Dimer Assay in Patients with Cancer Who Present with Suspected Acute Deep Venous Thrombosis (1999) (141)
- Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation (2011) (140)
- Anatomic distribution of deep vein thrombosis in pregnancy (2010) (138)
- A simple clinical model for the diagnosis of deep‐vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process (1998) (135)
- The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis. (1997) (132)
- Guidance for the prevention and treatment of the post-thrombotic syndrome (2016) (132)
- Paroxysmal Nocturnal Hemoglobinuria and the Risk of Venous Thrombosis: Review and Recommendations for Management of the Pregnant and Nonpregnant Patient (2000) (130)
- A Red Blood Cell Agglutination d-Dimer Test to Exclude Deep Venous Thrombosis in Pregnancy (2007) (130)
- How we manage venous thromboembolism during pregnancy. (2002) (129)
- Does this patient have deep vein thrombosis? (1998) (128)
- An Evaluation of d-Dimer in the Diagnosis of Pulmonary Embolism (2006) (127)
- D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. (2015) (127)
- Elevated cardiac troponin levels in patients with submassive pulmonary embolism. (2002) (126)
- Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin (1998) (126)
- Predicting Deep Venous Thrombosis in Pregnancy: Out in LEFt Field? (2009) (126)
- Heparin Effect on Bone Density (1990) (125)
- Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. (2008) (123)
- The Relationship of Antiphospholipid Antibodies to Thromboembolic Disease in Systemic Lupus Erythematosus: A Cross-Sectional Study (1991) (119)
- Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial. (1990) (119)
- Application of a Novel and Rapid Whole Blood Assay for D-Dimer in Patients with Clinically Suspected Pulmonary Embolism (1995) (115)
- Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. (1996) (111)
- Emery's elements of medical genetics (2015) (110)
- A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. (1992) (108)
- Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism (2004) (107)
- D‐dimer testing in pregnant patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis (2010) (106)
- Safety of Withholding Heparin in Pregnant Women With a History of Venous Thromboembolism (2001) (105)
- Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin (2003) (105)
- Use of different d‐dimer levels to exclude venous thromboembolism depending on clinical pretest probability (2004) (104)
- A latex D-dimer reliably excludes venous thromboembolism. (2001) (103)
- Accuracy of a portable International Normalization Ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. (1998) (101)
- Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded (2012) (101)
- Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism. (2006) (101)
- Intermittent compression units for severe post-phlebitic syndrome: a randomized crossover study. (1999) (97)
- A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement (2007) (97)
- A review of upper extremity deep vein thrombosis in pregnancy: unmasking the ‘ART’ behind the clot (2006) (97)
- The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin. (1996) (95)
- Venous thrombosis in patients who have undergone major hip or knee surgery: detection with compression US and impedance plethysmography. (1991) (93)
- Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times. (1999) (93)
- Low-molecular weight heparin in the treatment of patients with venous thromboembolism: the Columbus Investigators (1997) (92)
- Use of Hirulog in the prevention of venous thrombosis after major hip or knee surgery. (1994) (91)
- D-dimer in patients with clinically suspected pulmonary embolism. (1993) (89)
- A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy. (1997) (89)
- Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study. (1992) (88)
- Management of venous thromboembolism during pregnancy (2003) (88)
- Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. (2005) (85)
- Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study (2001) (84)
- Initial Treatment of Venous Thromboembolism (2004) (83)
- What determines the age at the menopause? (1991) (82)
- Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. (1995) (81)
- Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy (2002) (81)
- Relation of Factor V Leiden Genotype to Risk for Acute Deep Venous Thrombosis after Joint Replacement Surgery (1998) (81)
- Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case–control study (2005) (79)
- Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review (2006) (79)
- Assessment of deep vein thrombosis or pulmonary embolism by the combined use of clinical model and noninvasive diagnostic tests. (2000) (77)
- A comparison of three rapid D‐dimer methods for the diagnosis of venous thromboembolism (2001) (76)
- Low‐Molecular‐Weight Heparins: Are they all the Same? (2003) (75)
- Comparison of the Villalta and Ginsberg clinical scales to diagnose the post‐thrombotic syndrome: correlation with patient‐reported disease burden and venous valvular reflux (2006) (75)
- Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosis. (2003) (74)
- Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS) (2008) (73)
- The APTT Response of Pregnant Plasma to Unfractionated Heparin (2002) (72)
- Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin. (2001) (72)
- Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction? (2013) (72)
- Real‐world variability in dabigatran levels in patients with atrial fibrillation (2015) (72)
- Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism (2008) (71)
- Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism (1995) (70)
- Effectiveness of compression stockings to prevent the post-thrombotic syndrome (The SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial (2007) (68)
- D-Dimer and Thrombin-Antithrombin III Complexes in Patients with Clinically Suspected Pulmonary Embolism (1992) (67)
- Deep venous thrombosis and pulmonary embolism in pregnancy. (1992) (66)
- A Randomized Trial of Diagnostic Strategies after Normal Proximal Vein Ultrasonography for Suspected Deep Venous Thrombosis: d-Dimer Testing Compared with Repeated Ultrasonography (2005) (66)
- Subcutaneous Heparin Therapy during Pregnancy: a Need for Concern at the Time of Delivery (1991) (64)
- Factors that predict thrombosis in relatives of patients with venous thromboembolism. (2014) (64)
- Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials (2014) (63)
- The relationship between unprovoked venous thromboembolism, age, and acute myocardial infarction (2008) (62)
- Comparison of a Clinical Probability Estimate and Two Clinical Models in Patients with Suspected Pulmonary Embolism (2000) (62)
- Use of antithrombotic agents during pregnancy. (1995) (60)
- Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. (2009) (59)
- Selective d-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis (2013) (57)
- Use of antithrombotic agents during pregnancy. (1993) (57)
- Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents (2014) (57)
- Tetracycline sclerosis in the management of malignant pericardial effusion. (1985) (56)
- Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging (2013) (56)
- Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state. (1993) (55)
- The Use of the D-Dimer Test in Combination with Non-Invasive Testing Versus Serial Non-Invasive Testing Alone for the Diagnosis of Deep-Vein Thrombosis (1992) (54)
- Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosis. (1994) (53)
- Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy. (2002) (53)
- Ventilation-Perfusion Lung Scanning and the Diagnosis of Pulmonary Embolism: Improvement of Observer Agreement by the Use of a Lung Segment Reference Chart (1992) (52)
- New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions (2014) (52)
- Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post‐thrombotic syndrome (2015) (51)
- Relation between D‐dimer level, venous valvular reflux and the development of post‐thrombotic syndrome after deep vein thrombosis (2010) (51)
- Anticoagulants during pregnancy. (1989) (50)
- Graduated compression stockings to treat acute leg pain associated with proximal DVT (2014) (49)
- Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. (2018) (49)
- Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state [see comments] (1993) (48)
- Thrombosis in antithrombin‐III‐deficient persons. Report of a large kindred and literature review (1993) (48)
- Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia. (1997) (48)
- The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative Group. (1998) (46)
- Effect of warfarin on activated partial thromboplastin time in patients receiving heparin. (1998) (46)
- The role of D‐dimer in the diagnosis of venous thromboembolism (1997) (45)
- The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature. (2000) (44)
- Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis (2018) (44)
- Venous thromboembolism in older adults: A community-based study. (2014) (43)
- Dose-Response Study of Recombinant Factor VIIa / Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c 2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement (2001) (41)
- Differences in clinical presentation of deep vein thrombosis in men and women (2008) (41)
- Pre-operative Plasma Levels of Thrombin-Antithrombin III Complexes Correlate with the Development of Venous Thrombosis after Major Hip or Knee Surgery (1995) (41)
- 5 Anticoagulants in pregnancy: fetal effects (1997) (39)
- Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis. (2002) (39)
- Betrixaban (PRT054021): pharmacology, dose selection and clinical studies. (2014) (38)
- Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians. (2005) (35)
- Diagnostic strategies for the management of patients with clinically suspected deep‐vein thrombosis (1997) (35)
- Measurement of Markers of Activated Coagulation in Antithrombin III Deficient Subjects (1992) (34)
- Clinical practice. Treatment of deep-vein thrombosis. (2004) (34)
- A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal (2015) (33)
- Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials (2005) (33)
- Utility of ultrasound imaging of the lower extremities in the diagnostic approach in patients with suspected pulmonary embolism (2001) (30)
- Thrombosis in pregnancy (1997) (30)
- Free Protein S Deficiency May Be Found in Patients with Antiphospholipid Antibodies who Do not Have Systemic Lupus Erythematosus (1996) (30)
- Detection of previous proximal venous thrombosis with Doppler ultrasonography and photoplethysmography. (1989) (28)
- Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study. (2012) (28)
- Role of phenotypic and genetic testing in managing clopidogrel therapy. (2014) (28)
- Use of anticoagulants during pregnancy. (1989) (28)
- Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study. (2016) (28)
- Pharmacoeconomic Analysis of Fondaparinux Versus Enoxaparin for the Prevention of Thromboembolic Events in Orthopedic Surgery Patients (2004) (28)
- The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus (1999) (27)
- 3 Laboratory diagnosis of venous thromboembolism (1998) (27)
- Anticoagulants in pregnancy: fetal effects. (1997) (27)
- Pregnancy and prosthetic heart valves (1994) (27)
- Long‐term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d‐dimer results; A cohort study (2019) (27)
- 3 Laboratory diagnosis of venous thromboembolism (1998) (27)
- Multiple daily doses of acetyl‐salicylic acid (ASA) overcome reduced platelet response to once‐daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial (2015) (26)
- Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein Thrombosis (2005) (25)
- Intermittent compression units for the postphlebitic syndrome. A pilot study. (1989) (25)
- Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study (2016) (25)
- Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trials (2015) (25)
- Use of antithrombotic agents during pregnancy. (1998) (25)
- Thromboembolism and Pregnancy (1999) (25)
- Evaluation of a Soluble Fibrin Assay in Patients with Suspected Deep Vein Thrombosis (1995) (23)
- Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer. (2018) (23)
- Detection of pulmonary emboli with 99mTc-labeled anti-D-dimer (DI-80B3)Fab' fragments (ThromboView). (2011) (23)
- Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism. (2005) (23)
- The use of an indwelling Teflon catheter for subcutaneous heparin administration during pregnancy. A randomized crossover study. (1993) (22)
- The sensitivity and specificity of a red blood cell agglutination D-dimer assay for venous thromboembolism when performed on venous blood. (2002) (22)
- Impact of research investment on scientific productivity of junior researchers (2016) (22)
- Inherited thrombophilia and pregnancy associated venous thromboembolism. (2008) (22)
- Effects on Thrombin Generation of Single Injections of Hirulog™ in Patients with Calf Vein Thrombosis (1994) (22)
- Helical Computed Tomography and the Diagnosis of Pulmonary Embolism (2000) (21)
- A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions. (2006) (21)
- Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis (2019) (21)
- The Clinical Utility of a Rapid Bedside D-dimer Assay for Screening of Deep Vein Thrombosis following Orthopaedic Surgery (1997) (21)
- Laboratory diagnosis of venous thromboembolism. (1998) (20)
- Management of iliofemoral thrombosis in a pregnant patient with heparin resistance. (1997) (20)
- Low-dose warfarin in rehabilitating stroke survivors. (2002) (19)
- Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?—A Systematic Review (2020) (19)
- Reading between the (Guidelines). Management of submassive pulmonary embolism in the first trimester of pregnancy. (2008) (18)
- "ProC Global": A functional screening test that predicts recurrent venous thromboembolism (2005) (17)
- The Effect of Prothrombotic Blood Abnormalities on Risk of Deep Vein Thrombosis in Users of Hormone Replacement Therapy (2011) (17)
- Pregnancy and deep vein thrombosis. (2001) (16)
- Evaluation of the combination of a bedside D-dimer assay and enzyme-linked immunosorbent soluble fibrin assay in patients with suspected venous thromboembolism. (1997) (16)
- New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism (2005) (16)
- Evaluation of a Soluble Fibrin Assay in Patients with Suspected Pulmonary Embolism (1996) (16)
- Update in the diagnosis of deep-vein thrombosis and pulmonary embolism (2006) (16)
- The development and validation of an instrument to measure the quality of health research reports in the lay media (2017) (15)
- D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment. (2016) (15)
- Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study (2018) (14)
- Once versus twice daily aspirin after coronary bypass surgery: a randomized trial (2017) (14)
- Anticoagulant therapy with ancrod. (1993) (14)
- The diagnostic evaluation of deep vein thrombosis. (2004) (14)
- Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial. (2012) (13)
- Strategies for the diagnosis of deep vein thrombosis and pulmonary embolism. (2000) (13)
- A Negative D-dimer Excludes Recurrent Deep Vein Thrombosis: Results of a Multicentre Management Study. (2007) (13)
- Evidence for the Needs of Out-of-Hospital Thrombosis ProphylaxisThe Incidence of Symptomatic Venous Thromboembolism After Enoxaparin Prophylaxis in Lower Extremity Arthroplasty: A Cohort Study of 1,984 Patients (1998) (12)
- Diagnostic problems with venous thromboembolic disease in pregnancy. (1995) (12)
- Intra-arterial low-dose streptokinase infusion for superior mesenteric artery embolus. (1990) (11)
- Timing the First Postoperative Dose of Anticoagulants: Lessons Learned From Clinical Trials. (2015) (11)
- Anticoagulation for venous thromboembolism (2007) (11)
- Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis. (2000) (11)
- Heparin and Graduated Compression Stockings in Patients: Undergoing Fractured Hip Surgery (1991) (11)
- Arguments against Monitoring Levels of Anti-Factor Xa in Conjunction with Low-Molecular-Weight Heparin Therapy (2002) (11)
- Diagnosis of venous thromboembolism in pregnancy: a study in extrapolation or a science in evolution? (2009) (10)
- A Multicenter Randomized Placebo Controlled Trial of Compression Stockings to Prevent the Post-Thrombotic Syndrome After Proximal Deep Venous Thrombosis: The S.O.X. Trial (2012) (10)
- Routine Stocking Therapy after Deep Venous Thrombosis: A Clinical Dilemma (2004) (10)
- New anticoagulants for venous thromboembolic disease (2005) (10)
- Compression stockings to prevent post-thrombotic syndrome – Authors' reply (2014) (9)
- New antithrombotics. (1995) (9)
- Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides (2013) (9)
- Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism. (2000) (8)
- Venous thrombosis of the upper extremities (2001) (8)
- Wells PS, Hirsh J, Anderson DR, et al: Accuracy of clinical assessment of deep-vein thrombosis (1995) (8)
- The cost and benefit of prophylaxis against deep-vein thrombosis in elective hip replacement (1997) (8)
- Low molecular weight heparin and asa therapy in women with autoantibodies and unexplained recurrent fetal loss (U-RFL) (1997) (7)
- In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets (2018) (7)
- Comparison of Performance of Two Clinical Scales To Diagnose the Post-Thrombotic Syndrome: Correlation with Patient-Reported Disease Burden and Valvular Reflux. (2005) (6)
- Evidence-based hematology (2008) (6)
- Real‐world variability in dabigatran levels in patients with atrial fibrillation: reply (2015) (6)
- Anticoagulant treatment of deep vein thrombosis and pulmonary embolism. (2006) (6)
- Pseudothrombosis in pregnancy. (1988) (5)
- Highlights of the Year in JACC 2005. (2006) (5)
- DIAGNOSIS OF DEEP-VEIN THROMBOSIS (1989) (5)
- DVT and pulmonary embolism: choosing the right diagnostic tests for patients at risk. (1995) (5)
- Direct oral anticoagulants (DOACs) and pregnancy: A plea for better information (2016) (5)
- Evaluation of a VENOus-Return Assist Device (Venowave™) To Treat Severe Post-Thrombotic Syndrome (VENOPTS): A Randomized Controlled Trial. (2006) (5)
- Women's Vascular Health (2006) (5)
- Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery (2018) (5)
- Predictors of the Development of Post-Thrombotic Syndrome after Acute Symptomatic Deep Vein Thrombosis: Two-Year Results from a Canadian Multicenter Prospective Cohort Study (The VETO Study). (2005) (5)
- Preventing Thromboembolic Complications in Older Orthopaedic Surgery Patients (1999) (4)
- Advances in the Diagnosis of Venous Thromboembolism A Multimodal Approach (2001) (4)
- Uses of heparin. Ancrod for heparin induced thrombocytopenia. (1993) (4)
- 81 – Peripheral Venous Disease (2012) (4)
- Heparin prophylaxis during pregnancy. (1990) (4)
- Economic Burden and Cost Determinants of Deep Venous Thrombosis During the Two Years Following Diagnosis: a Prospective Evaluation (2010) (3)
- The diagnostic evaluation of pulmonary embolism. (2005) (3)
- Rebuttal to Partsch et al. “Pain relief by compression in acute DVT. A critique of Kahn et al.“ Thromb Haemost 2015; 113: 906. (2015) (3)
- Management of Venous Thromboembolism in Pregnancy (2009) (3)
- The Rational Clinical Examination Does This Patient Have Deep Vein Thrombosis (2001) (3)
- Inflammation Markers and The Risk Of Post Thrombotic Syndrome: Results From The Bio-Sox Study (2013) (3)
- Wormy wood? (1997) (3)
- Uterine vein thrombosis: an unusual variant of pelvic vein thrombophlebitis. (1997) (3)
- Management of pregnant women with prosthetic heart valves. (1998) (2)
- The development and introduction of biosimilar anticoagulants – focus on enoxaparin (2012) (2)
- Optimum Use of Anticoagulants in Pregnancy (1988) (2)
- Evaluation of a venous-return assist device (venowave) to treat post-thrombotic syndrome: a phase II study (2003) (2)
- Anticoagulation in pregnancy. (1999) (2)
- Anticoagulant treatment of deep vein thrombosis and pulmonary embolism. (2008) (2)
- Use of antithrombotic agents pregnancy (1992) (2)
- Bleeding after initiation of anticoagulant therapy for deep vein thrombosis. (1999) (2)
- Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada (2018) (2)
- Can a Single Measurement of Apixaban Levels Identify Patients at Risk of Overexposure? A Prospective Cohort Study (2021) (2)
- Bleeding in Patients with Atrial Fibrillation Treated with Non Vitamin K Antagonist Oral Anticoagulants: A Population-Based Study (2014) (2)
- Incidence, timing of onset and severity of post-thrombotic syndrome after acute symptomatic deep vein thrombosis: Two-year results from a Canadian multicenter prospective cohort study (The VETO study) (2005) (2)
- Bleeding in Patients with Atrial Fibrillation Treated with Different Doses of Direct Oral Anticoagulants and Vitamin K Antagonists: A Population-Based Study (2016) (2)
- A randomized comparison of dalteparin versus unfractionated heparin during percutaneous coronary interventions (2003) (2)
- Predictors Of The Post-Thrombotic Syndrome In a Large Cohort Of Patients With Proximal DVT: Secondary Analysis Of The Sox Trial (2013) (1)
- EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT) (2007) (1)
- A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke (2020) (1)
- How I treat How we manage venous thromboembolism during pregnancy (2002) (1)
- Traitement antithrombotique pendant la grossesse (2000) (1)
- Influence of Warfarin on Symptoms of Fatigue: Findings of a Randomized Trial (2005) (1)
- Determinants of Health-Related Quality of Life after Deep Venous Thrombosis: Two-Year Results from a Canadian Multicenter Prospective Cohort Study (The VETO Study). (2005) (1)
- Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable? (2021) (1)
- Comparison ofximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement (2003) (1)
- Mortality benefit in the COMPASS trial: is it related to superior statistical power or better efficacy and safety? (2020) (1)
- Is There a Relationship Between the Intensity of Heparin Treatment and Recurrent Thomboembolism? (1997) (1)
- Randomized trial to examine the effect of ASA dose or ASA dosing frequency on ASA resistance after coronary artery bypass graft surgery (2013) (1)
- Thrombosis in Antithrombin-III-deficient Persons (2020) (1)
- The national physicians cooperative (NPC) tissue study: ovarian tissue from pediatric patients removed for cryopreservation contains follicles regardless of treatment history (2014) (1)
- Ximelagatran for prevention of venous thromboembolism in knee replacement (2004) (1)
- The Effectiveness Of 30-40 Mm Hg Compression Stockings To Treat Acute Leg Pain Associated With Proximal Deep Vein Thrombosis: Results From The Sox Randomized Controlled Trial (2013) (1)
- Clinical assessment and o-dimer testing in deep venous thrombosis. Authors' reply (2002) (0)
- Diagnosis of deep vein th SUMMARY (2007) (0)
- O8 Predicting DVT in pregnancy: out in “left” field? (2009) (0)
- Effect of patient's sex on risk of recurrent venous thromboembolism : a meta-analysis. Commentary (2007) (0)
- D-Dimerin PatientsWithClinically SuspectedPulmonary Embolism* (2017) (0)
- Ce patient a-t-il une embolie pulmonaire ? (2004) (0)
- D-dimer in patients with clinically suspected pulmonary embolism. 1993. (2009) (0)
- Prediction Rules Must Be Developed According to Methodological Guidelines (2010) (0)
- Venous Return Assist Devices for Intermittent Claudication: A Randomized Controlled Trial Utilizing a Sham Comparator (2019) (0)
- Hodgkin's Disease 1985. (1985) (0)
- Role of Gender in the Clinical Presentation of a First Deep Venous Thrombosis (DVT) in Outpatients. (2006) (0)
- Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial (2003) (0)
- Thromboembolism and pregnancy. (2001) (0)
- Thrombosis research and the future (2003) (0)
- THROMBOSIS IN ANTITHROMBIN-III DEFICIENCY. REPLY (1992) (0)
- Measures of ovarian reserve in female cancer patients compared to naturally aging women (2008) (0)
- A Randomized, Controlled Trial of Varying D-Dimer Cutpoints According to Clinical Pretest Probability Compared with a Uniform D-Dimer Cutpoint for Diagnosis of Deep Vein Thrombosis (2010) (0)
- No magic formula: age is the most important factor in predicting return to baseline levels of ovarian reserve after cancer therapy (2018) (0)
- THROMBOSIS AND HEMOSTASIS Factors that predict thrombosis in relatives of patients with venous thromboembolism (2014) (0)
- Low-Molecular-Weight Heparin Use in Pregnancy (2002) (0)
- Abstract (2003) (0)
- Acute Ovarian Failure and Premature Ovarian Insufficiency in Childhood Cancer Survivors Who Received Radiotherapy: A PENTEC Report (2022) (0)
- Compression ultrasound was not useful in symptom-free venous thrombosis (1994) (0)
- Thromboses veineuses profondes : Héparine de bas poids moléculaire à domicile versus héparine non fractionnée à l'hôpital (1996) (0)
- Hormonal Therapy in Women (2006) (0)
- 504 Subtle Differences in Commercial Heparins Can Have Serious Consequences for Cardiopulmonary Bypass Patients: a randomized controlled trial (2012) (0)
- Review: Low-molecular weight heparin reduces the risk for developing deep-vein thrombosis and pulmonary embolism in patients having orthopedic surgery (1992) (0)
- Absence of thrombin generation during therapy with a highly purified solvent/detergent treated factor IX concentrate (1993) (0)
- Author Index / Subject Index, Vol. 25, 1995 (1995) (0)
- Use of Low Dose Oral Vitamin K in the Treatment of Patients with INR Values of More Than 10.0. (2005) (0)
- Pregnancy increases the risk of venous thromboembolism (VTE) but the true incidence is unknown. The risk of VTE continues in the post-partum period and is probably higher than during pregnancy. (2004) (0)
- Surgical Myocardial Revascularization in Patients with Acute Myocardial Infarction and Cardiogenic Shock: Data from the GERMIN-SURG Registry (2022) (0)
- A 52-year-old-woman with no history of venous thromboembolism presents with a four-day history of discomfort in her left calf. Proximal deep-vein thrombosis is diag- nosed by compression ultrasonography. How should her case be managed? (2004) (0)
- Low-molecular weight heparin in the treatment of patients with venous (2014) (0)
- 14 A red blood cell agglutination D-dimer test for the diagnosis of DVT in pregnancy: a prospective cohort study (2007) (0)
- IMPEDANCE PLETHYSMOGRAPHY FOR SUSPECTED DEEP-VEIN THROMBOSIS. AUTHORS' REPLY (1995) (0)
- Relationship between menopausal symptoms and ovarian reserve in reproductive-aged cancer survivors (2018) (0)
- d-Dimer Testing in Pregnancy: Clinically Useful, but at What Cost? (2008) (0)
- Deep vein thrombosis and duplex ultrasound. (1990) (0)
- CLINICAL MODEL FOR MANAGEMENT OF PULMONARY EMBOLISM. AUTHORS' REPLY (1999) (0)
- MONITORING HEPARIN THERAPY. AUTHORS' REPLY (1994) (0)
- C.W. Colwell Jr., S.D. Berkowitz, J.R. Lieberman, P.C. Comp, J.S, Ginsberg, G. Paiement, J. McElhattan, A. W. Roth, and C. W. Francis reply [10] (2006) (0)
- Laboratory monitoring of oral anticoagulant therapy. (1989) (0)
- Chapter 61. Venous Thromboembolic Disease (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jeffrey S. Ginsberg?
Jeffrey S. Ginsberg is affiliated with the following schools: